Lv6
1762 积分 2023-12-04 加入
Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugates
11天前
已完结
Contribution of linker stability to the activities of engineered antibody–drug conjugates based on maytansinoids or auristatins
12天前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
12天前
已完结
Reducing hydrophobicity of homogeneous antibody–drug conjugates via site-selective conjugation improves pharmacokinetics and therapeutic index
12天前
已完结
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
12天前
已完结
OA10.03 Phase I/II Study of Iza-Bren (BL-B01D1) as Monotherapy in Patients With Locally Advanced or Metastatic EGFR Mutated NSCLC
13天前
已关闭
Bispecific antibodies: a mechanistic review of the pipeline
30天前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
1个月前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
2个月前
已完结
皖公网安备34019202002308
